Premium
PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis‐B surface antigen and anti‐HBS antibodies
Author(s) -
Huang Xiangyan,
Qin Yanghua,
Zhang Peng,
Tang Gusheng,
Shi Qingfen,
Xu Jun,
Qi Falian,
Shen Qian
Publication year - 2010
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.21669
Subject(s) - hbsag , hepatitis b virus , virology , antibody , hepatitis b , antigen , genotyping , virus , mutation , biology , medicine , microbiology and biotechnology , gene , immunology , genotype , genetics
Hepatitis B surface antigen (HBsAg) and anti‐HBs antibodies (anti‐HBs) may coexist in certain chronic hepatitis B (CHB) patients. This study was designed to further explore the relationship between this coexistence and hepatitis B Virus (HBV) preS deletions. Sera of 28 patients carrying both HBsAg and anti‐HBs (Group I) and those of another 28 HBsAg positive but anti‐HBs negative patients (Group II) were collected from CHB patients. Direct sequencing of polymerase chain reaction products or sequencing of clones was applied to both groups to determine sequences of HBV preS and S genes. Genotyping of the S gene indicated that all sampled HBVs were either Genosubtype Ba or Genosubtype Ce. Seven samples in Group I harbored HBV preS deletion mutations. Three of the seven samples showed large deletion mutations in 3′ terminus of preS1 and co‐existence of the mutant type and the full‐length wild type, and the remaining four samples showed deletion mutations in 5′ terminus of preS2. All mutant strains were found to be genosubtype Ce. Only two samples in Group I showed G145R/A mutation. Only one sample in Group II contained preS deletion mutation. It is therefore concluded that HBV preS deletion mutations are likely to be related to the coexistence of HBsAg and anti‐HBs in CHB patients ( P ‐value = 0.024). Some immune reactions may select for the preS deletion in CHB patients with anti‐HBs, the possible marker for immune selection. J. Med. Virol. 82:23–31, 2010. © 2009 Wiley‐Liss, Inc.